Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

Due to the positive association between neoadjuvant chemotherapy (NACT) and the promising early response rates of patients with triple negative breast cancer (TNBC), including probabilities of pathological complete response, NACT is increasingly used in TNBC management. Liquid biopsy-based biomarker...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Oncol
Autors principals: Ritter, Andrea, Hirschfeld, Marc, Berner, Kai, Rücker, Gerta, Jäger, Markus, Weiss, Daniela, Medl, Markus, Nöthling, Claudia, Gassner, Sandra, Asberger, Jasmin, Erbes, Thalia
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6910196/
https://ncbi.nlm.nih.gov/pubmed/31789396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2019.4920
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars